# pathway_0022: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0022.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSPHISPSKDTPSQRLPIPLSLPTHLGLLAKAYGVPPASILQLAWGLVLRCYFTTSSSRWGTIDMAHEYKEKKNLPIRCEVLELDDTRSIGWILQNWNDPSVHRHLPAEEDTSNVPVSAGSIVILTEDAKDLEVLRDFELTAEWIICFSTSTEKPLLRLSWRPDVIHSELASHLAQLLERALDTTFLSPDIPLSQINLFSILDHQKLLQWNHQYPQSVNRLVHEMFEDMVAARPQATAVAAWDGEVTYQQLDRLSTRLAIKLQTIDLQPESIVALCFEKSVWAIVAMLGVLRAGGAFLHIDPKHPTARQQAMISTTAARIILCSEQTRDTVSRFDSESLSLVVDRKMFAQEPDHKQVALPSPNNLGPRNAAYIVCTSGSTGLPKAIVVEHVSLCTSVTAQAEAMAVGGESRILQYAAYTFDVSVGDVFTALTHGACVCIPSDWERTQDLVGAINRLDVNQACLTSTVASFLTPMNVPKLQKLTLGGEPASKQCIDLWSGKVALKNVYGPAECTVWCVIQKNASSEIPASNIGRGIGARTWIVHPENHNQLMPIGAVGELLIEGPLVARGYLNDAERTTAVFLERAPSWLATFGPLPPQTRFYKTGDLARFEQNGTLFFEGRKDTQVKLRGQRIELGEIEYQIQQACNPVPPLAVELIETKDLQAPLLGAFITWTGGLEISLDQSAVPNGLGPDLDARSHFNELVSRIQANIDRTLPPYMMPGLYIPVQKLPLSTSGKLDRKVLRQYCTQHTRSFLTASEAESSDVIADDATKDDVALHEIVNPGEITLAQLWAHALGRRMESINAKDNFLSLGGDSLAAMRLVNLAARDAQVTLTVANIFESPVLADQARLLRPLSKTKSLAPFELMTRGEASIEDIVGFAAQQCRLLPAQIEDVYPCTPLQEEMMRDSLSNDRTQMGQEVVQISEELDLVRYQVACASVYRRFPILRTRFIEHSGRLVQVVVREDLCWKQPTSLAEYKALDSRERPALGKPLTRWALTSDGTHFILSLHHAMFDGITLGQIQGAIYAVYQCIPLPPPSVSFATFLAHLDDQNAPLSQESQRFWQSYLCPSASLDASITPETQKIDRPRASCGTQRLVQFTSGEVSALQRHGLTEATLVRGAWACTLARHQQKPHASAFSDVIFGTMLTGRNFHLPGVDMLAAPSLTHVPIRIRIDEGDLNGHSARALLARVQADATAMIPYEHDGMNRIRSIEVQTRAVFNRIRTLLVIQPIPEGLTSVSTSPFPGSIVSGPRVEAKEMGHFHWYGLLVECTLLPTKGFFVRVSYDNKMFGTEQVESLLDDYSTTLHTLANGLMDTDIPASLHV

[Multiple Choices]
A. Lipid metabolism. .
B. Antifungal biosynthesis. .
C. spheroidene biosynthesis. .
D. One-carbon metabolism
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The entry identifies the protein as a nonribosomal peptide synthetase and cites a publication for its function and pathway annotation. This supports choice B as a database- and literature-linked annotation, though the excerpts do not independently establish the experimental basis of the pathway assignment.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is compatible with a large biosynthetic enzyme such as a nonribosomal peptide synthetase, which supports a broad biosynthesis role. That does not establish the specific antifungal pathway rather than another natural-product pathway.


**Missing item-specific fact**

> The protein’s association with the lanomycin biosynthetic cluster and its pathway annotation as antifungal biosynthesis are not supplied in the question.


**Reason**

> Identifying the precise pathway requires protein- or cluster-specific annotation or literature knowledge; general sequence reasoning does not distinguish the specific pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence alone does not make the pathway clear, but the cited annotation supports B among the listed choices.


### Important caveats

- The reviewer-only source identifies the matched sequence as a nonribosomal peptide synthetase from Pyrenophora dematioidea and annotates its pathway as antifungal biosynthesis.
- The pathway annotation is linked to a publication, but the supplied evidence excerpts do not independently validate the experimental strength of that assignment.
- The source identity and annotation were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is compatible with a large biosynthetic enzyme such as a nonribosomal peptide synthetase, which supports a broad biosynthesis role. That does not establish the specific antifungal pathway rather than another natural-product pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s association with the lanomycin biosynthetic cluster and its pathway annotation as antifungal biosynthesis are not supplied in the question.",
    "reason": "Identifying the precise pathway requires protein- or cluster-specific annotation or literature knowledge; general sequence reasoning does not distinguish the specific pathway."
  },
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The entry identifies the protein as a nonribosomal peptide synthetase and cites a publication for its function and pathway annotation. This supports choice B as a database- and literature-linked annotation, though the excerpts do not independently establish the experimental basis of the pathway assignment."
  },
  "important_caveats": [
    "The reviewer-only source identifies the matched sequence as a nonribosomal peptide synthetase from Pyrenophora dematioidea and annotates its pathway as antifungal biosynthesis.",
    "The pathway annotation is linked to a publication, but the supplied evidence excerpts do not independently validate the experimental strength of that assignment.",
    "The source identity and annotation were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone does not make the pathway clear, but the cited annotation supports B among the listed choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The entry identifies the protein as a nonribosomal peptide synthetase and cites a publication for its function and pathway annotation. This supports choice B as a database- and literature-linked annotation, though the excerpts do not independently establish the experimental basis of the pathway assignment.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is compatible with a large biosynthetic enzyme such as a nonribosomal peptide synthetase, which supports a broad biosynthesis role. That does not establish the specific antifungal pathway rather than another natural-product pathway.",
    "missing_item_specific_fact": "The protein’s association with the lanomycin biosynthetic cluster and its pathway annotation as antifungal biosynthesis are not supplied in the question.",
    "reason": "Identifying the precise pathway requires protein- or cluster-specific annotation or literature knowledge; general sequence reasoning does not distinguish the specific pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone does not make the pathway clear, but the cited annotation supports B among the listed choices."
  },
  "important_caveats": [
    "The reviewer-only source identifies the matched sequence as a nonribosomal peptide synthetase from Pyrenophora dematioidea and annotates its pathway as antifungal biosynthesis.",
    "The pathway annotation is linked to a publication, but the supplied evidence excerpts do not independently validate the experimental strength of that assignment.",
    "The source identity and annotation were not provided to the evaluated model."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches UniProt entry P0DXV4 (LAN2_PYRDE, 1325 AA, sequence SHA256 matched). The UniProt PATHWAY comment explicitly states 'Antifungal biosynthesis' (ECO:0000305, PubMed:33857369). The protein is annotated as a Nonribosomal peptide synthetase / Lanomycin biosynthesis cluster protein 1 from Pyrenophora dematioidea. The underlying paper (Liu et al., JACS 2021) describes genome mining of CYP51-inhibitor biosynthetic gene clusters, providing experimental context for the antifungal pathway assignment.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains recognizable NRPS domain signatures (e.g., 'TSGSTG' adenylation-domain motif, 'HHAMFDG' condensation-domain motif), which could allow identification as a nonribosomal peptide synthetase. NRPS enzymes are involved in secondary metabolite biosynthesis, which could help eliminate lipid metabolism (fatty acid synthases/desaturases), spheroidene biosynthesis (carotenoid desaturases/cyclases), and one-carbon metabolism (folate/methionine enzymes) as unlikely NRPS pathways. However, the specific assignment to 'antifungal' biosynthesis (vs. antibacterial, siderophore, immunosuppressant, or other NRPS-product pathways) cannot be derived from sequence features alone.


**Missing item-specific fact**

> Knowledge that this particular NRPS is part of the lanomycin biosynthetic gene cluster and that lanomycin is specifically an antifungal (CYP51 inhibitor) compound. The sequence provides no information distinguishing this NRPS's product as antifungal rather than antibacterial or another secondary metabolite class.


**Reason**

> While NRPS domain architecture recognition might narrow choices by eliminating clearly non-NRPS pathways (A, C, D), the specific pathway label 'Antifungal biosynthesis' requires item-specific knowledge of the gene cluster context and product bioactivity. NRPS enzymes produce diverse secondary metabolites; the antifungal designation is a database annotation derived from the underlying genomics paper, not a property inferable from the amino acid sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the four choices, only 'Antifungal biosynthesis' is a secondary-metabolite/NRPS pathway. Lipid metabolism, spheroidene biosynthesis, and one-carbon metabolism are clearly distinct pathway classes not associated with NRPS enzymes. So if NRPS is recognized, B is the only viable option. However, this elimination still depends on the specific pathway taxonomy used by the benchmark.


### Important caveats

- The UniProt entry was first public on 2025-02-05; the benchmark construction date is unknown. If the benchmark was constructed before this date, the annotation source may differ.
- The pathway annotation carries evidence code ECO:0000305 (inferred from curator), though the underlying PubMed reference (33857369) provides experimental genome-mining support.
- The protein is 1325 AA, which is relatively small for a multi-module NRPS; it may represent a single module or a partial assembly line, which could complicate domain recognition.
- The reviewer-only evidence was not available to the evaluated model; the model only sees the raw sequence and four choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable NRPS domain signatures (e.g., 'TSGSTG' adenylation-domain motif, 'HHAMFDG' condensation-domain motif), which could allow identification as a nonribosomal peptide synthetase. NRPS enzymes are involved in secondary metabolite biosynthesis, which could help eliminate lipid metabolism (fatty acid synthases/desaturases), spheroidene biosynthesis (carotenoid desaturases/cyclases), and one-carbon metabolism (folate/methionine enzymes) as unlikely NRPS pathways. However, the specific assignment to 'antifungal' biosynthesis (vs. antibacterial, siderophore, immunosuppressant, or other NRPS-product pathways) cannot be derived from sequence features alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Knowledge that this particular NRPS is part of the lanomycin biosynthetic gene cluster and that lanomycin is specifically an antifungal (CYP51 inhibitor) compound. The sequence provides no information distinguishing this NRPS's product as antifungal rather than antibacterial or another secondary metabolite class.",
    "reason": "While NRPS domain architecture recognition might narrow choices by eliminating clearly non-NRPS pathways (A, C, D), the specific pathway label 'Antifungal biosynthesis' requires item-specific knowledge of the gene cluster context and product bioactivity. NRPS enzymes produce diverse secondary metabolites; the antifungal designation is a database annotation derived from the underlying genomics paper, not a property inferable from the amino acid sequence alone."
  },
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches UniProt entry P0DXV4 (LAN2_PYRDE, 1325 AA, sequence SHA256 matched). The UniProt PATHWAY comment explicitly states 'Antifungal biosynthesis' (ECO:0000305, PubMed:33857369). The protein is annotated as a Nonribosomal peptide synthetase / Lanomycin biosynthesis cluster protein 1 from Pyrenophora dematioidea. The underlying paper (Liu et al., JACS 2021) describes genome mining of CYP51-inhibitor biosynthetic gene clusters, providing experimental context for the antifungal pathway assignment."
  },
  "important_caveats": [
    "The UniProt entry was first public on 2025-02-05; the benchmark construction date is unknown. If the benchmark was constructed before this date, the annotation source may differ.",
    "The pathway annotation carries evidence code ECO:0000305 (inferred from curator), though the underlying PubMed reference (33857369) provides experimental genome-mining support.",
    "The protein is 1325 AA, which is relatively small for a multi-module NRPS; it may represent a single module or a partial assembly line, which could complicate domain recognition.",
    "The reviewer-only evidence was not available to the evaluated model; the model only sees the raw sequence and four choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, only 'Antifungal biosynthesis' is a secondary-metabolite/NRPS pathway. Lipid metabolism, spheroidene biosynthesis, and one-carbon metabolism are clearly distinct pathway classes not associated with NRPS enzymes. So if NRPS is recognized, B is the only viable option. However, this elimination still depends on the specific pathway taxonomy used by the benchmark."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches UniProt entry P0DXV4 (LAN2_PYRDE, 1325 AA, sequence SHA256 matched). The UniProt PATHWAY comment explicitly states 'Antifungal biosynthesis' (ECO:0000305, PubMed:33857369). The protein is annotated as a Nonribosomal peptide synthetase / Lanomycin biosynthesis cluster protein 1 from Pyrenophora dematioidea. The underlying paper (Liu et al., JACS 2021) describes genome mining of CYP51-inhibitor biosynthetic gene clusters, providing experimental context for the antifungal pathway assignment.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains recognizable NRPS domain signatures (e.g., 'TSGSTG' adenylation-domain motif, 'HHAMFDG' condensation-domain motif), which could allow identification as a nonribosomal peptide synthetase. NRPS enzymes are involved in secondary metabolite biosynthesis, which could help eliminate lipid metabolism (fatty acid synthases/desaturases), spheroidene biosynthesis (carotenoid desaturases/cyclases), and one-carbon metabolism (folate/methionine enzymes) as unlikely NRPS pathways. However, the specific assignment to 'antifungal' biosynthesis (vs. antibacterial, siderophore, immunosuppressant, or other NRPS-product pathways) cannot be derived from sequence features alone.",
    "missing_item_specific_fact": "Knowledge that this particular NRPS is part of the lanomycin biosynthetic gene cluster and that lanomycin is specifically an antifungal (CYP51 inhibitor) compound. The sequence provides no information distinguishing this NRPS's product as antifungal rather than antibacterial or another secondary metabolite class.",
    "reason": "While NRPS domain architecture recognition might narrow choices by eliminating clearly non-NRPS pathways (A, C, D), the specific pathway label 'Antifungal biosynthesis' requires item-specific knowledge of the gene cluster context and product bioactivity. NRPS enzymes produce diverse secondary metabolites; the antifungal designation is a database annotation derived from the underlying genomics paper, not a property inferable from the amino acid sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, only 'Antifungal biosynthesis' is a secondary-metabolite/NRPS pathway. Lipid metabolism, spheroidene biosynthesis, and one-carbon metabolism are clearly distinct pathway classes not associated with NRPS enzymes. So if NRPS is recognized, B is the only viable option. However, this elimination still depends on the specific pathway taxonomy used by the benchmark."
  },
  "important_caveats": [
    "The UniProt entry was first public on 2025-02-05; the benchmark construction date is unknown. If the benchmark was constructed before this date, the annotation source may differ.",
    "The pathway annotation carries evidence code ECO:0000305 (inferred from curator), though the underlying PubMed reference (33857369) provides experimental genome-mining support.",
    "The protein is 1325 AA, which is relatively small for a multi-module NRPS; it may represent a single module or a partial assembly line, which could complicate domain recognition.",
    "The reviewer-only evidence was not available to the evaluated model; the model only sees the raw sequence and four choices."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt annotation identifies the protein as a nonribosomal peptide synthetase and assigns it to antifungal biosynthesis, citing a publication that reports function and pathway information. This supports the key as a curated pathway annotation, though the cited evidence code does not by itself establish a direct experimental pathway measurement.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The long sequence contains the characteristic modular architecture and conserved motifs of a nonribosomal peptide synthetase. Transferable knowledge links such enzymes to specialized peptide-metabolite biosynthesis, making antifungal biosynthesis a meaningful fit among these choices; spheroidene biosynthesis is carotenoid-related, while lipid and one-carbon metabolism are not the expected roles of a large modular NRPS.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence supports a family-level inference that distinguishes B from the offered alternatives without requiring recall of this exact protein's record. NRPS architecture alone does not prove that its product is antifungal, so the choice is a defensible probabilistic inference rather than a uniquely established product assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No other offered pathway is comparably supported by the sequence's NRPS architecture.


### Important caveats

- The pathway support comes from a curated annotation with a literature citation; the supplied excerpts do not independently detail or validate the underlying experiments.
- NRPS architecture indicates specialized metabolite biosynthesis generally, not antifungal activity specifically.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence contains the characteristic modular architecture and conserved motifs of a nonribosomal peptide synthetase. Transferable knowledge links such enzymes to specialized peptide-metabolite biosynthesis, making antifungal biosynthesis a meaningful fit among these choices; spheroidene biosynthesis is carotenoid-related, while lipid and one-carbon metabolism are not the expected roles of a large modular NRPS.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence supports a family-level inference that distinguishes B from the offered alternatives without requiring recall of this exact protein's record. NRPS architecture alone does not prove that its product is antifungal, so the choice is a defensible probabilistic inference rather than a uniquely established product assignment."
  },
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies the protein as a nonribosomal peptide synthetase and assigns it to antifungal biosynthesis, citing a publication that reports function and pathway information. This supports the key as a curated pathway annotation, though the cited evidence code does not by itself establish a direct experimental pathway measurement."
  },
  "important_caveats": [
    "The pathway support comes from a curated annotation with a literature citation; the supplied excerpts do not independently detail or validate the underlying experiments.",
    "NRPS architecture indicates specialized metabolite biosynthesis generally, not antifungal activity specifically."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered pathway is comparably supported by the sequence's NRPS architecture."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies the protein as a nonribosomal peptide synthetase and assigns it to antifungal biosynthesis, citing a publication that reports function and pathway information. This supports the key as a curated pathway annotation, though the cited evidence code does not by itself establish a direct experimental pathway measurement.",
    "evidence_ids": ["C4", "C5", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The long sequence contains the characteristic modular architecture and conserved motifs of a nonribosomal peptide synthetase. Transferable knowledge links such enzymes to specialized peptide-metabolite biosynthesis, making antifungal biosynthesis a meaningful fit among these choices; spheroidene biosynthesis is carotenoid-related, while lipid and one-carbon metabolism are not the expected roles of a large modular NRPS.",
    "missing_item_specific_fact": "",
    "reason": "The sequence supports a family-level inference that distinguishes B from the offered alternatives without requiring recall of this exact protein's record. NRPS architecture alone does not prove that its product is antifungal, so the choice is a defensible probabilistic inference rather than a uniquely established product assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered pathway is comparably supported by the sequence's NRPS architecture."
  },
  "important_caveats": [
    "The pathway support comes from a curated annotation with a literature citation; the supplied excerpts do not independently detail or validate the underlying experiments.",
    "NRPS architecture indicates specialized metabolite biosynthesis generally, not antifungal activity specifically."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV4 explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305|PubMed:33857369). The protein is a nonribosomal peptide synthetase (EC 6.3.2.-) in the lanomycin biosynthesis cluster of the fungus Pyrenophora dematioidea. Lanomycin is a known polyene antifungal compound. The reference (Liu et al. 2021, JACS) describes targeted genome mining of CYP51-inhibitor biosynthetic gene clusters, confirming the antifungal biosynthesis context. The sequence matches the benchmark exactly.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [H3](#evidence-h3), [H1](#evidence-h1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence displays hallmark nonribosomal peptide synthetase (NRPS) domain signatures: the 'SGSTG' adenylation-domain motif, 'GGES' and 'GGDS' A-domain sub-motifs, and the 'HHxxxDG' condensation-domain signature (e.g., 'HHAMFDGITLGQ'). NRPS enzymes are large multi-modular assembly-line catalysts that produce secondary metabolites (peptides, lipopeptides, polyene-polyketide hybrids). From transferable knowledge of fungal secondary metabolism, NRPS clusters in fungi commonly synthesize antifungal agents (echinocandins, gliotoxin, lanomycin-type polyenes, etc.). Among the four choices: (A) Lipid metabolism relies on fatty acid synthases, desaturases, and elongases—not NRPS; (C) Spheroidene is a carotenoid synthesized by phytoene synthase, carotenoid desaturases, and lycopene cyclases—not NRPS; (D) One-carbon metabolism involves folate-cycle enzymes (SHMT, methionine synthase, formyltransferases)—not NRPS. Only (B) Antifungal biosynthesis is mechanistically consistent with a large NRPS producing a fungal secondary metabolite. A model recognizing NRPS architecture can eliminate A, C, and D on mechanistic grounds and select B.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognition of NRPS domain signatures (SGSTG, HHxxxDG, GGES/GGDS) from the sequence, combined with general knowledge that fungal NRPS enzymes produce secondary metabolites such as antifungals rather than primary metabolites (lipids, carotenoids, one-carbon units), provides a concrete and credible inference that distinguishes B from A, C, and D without requiring the specific UniProt annotation for this protein.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent mechanistically distinct pathway classes. NRPS enzymes are incompatible with lipid metabolism (A), carotenoid/spheroidene biosynthesis (C), and one-carbon metabolism (D) based on well-established biochemistry. Only antifungal biosynthesis (B) is consistent with NRPS function in fungi. No alternative choice is defensible.


### Important caveats

- The UniProt pathway annotation carries evidence code ECO:0000305 (inferred by curator from PubMed:33857369), not direct experimental pathway reconstitution, though the supporting paper provides genomic and functional evidence.
- The entry was first publicly released in February 2025; the author's source snapshot is unknown but the sequence matches exactly.
- NRPS domain recognition from sequence alone is a computational inference; however, the domain signatures here are canonical and unambiguous.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence displays hallmark nonribosomal peptide synthetase (NRPS) domain signatures: the 'SGSTG' adenylation-domain motif, 'GGES' and 'GGDS' A-domain sub-motifs, and the 'HHxxxDG' condensation-domain signature (e.g., 'HHAMFDGITLGQ'). NRPS enzymes are large multi-modular assembly-line catalysts that produce secondary metabolites (peptides, lipopeptides, polyene-polyketide hybrids). From transferable knowledge of fungal secondary metabolism, NRPS clusters in fungi commonly synthesize antifungal agents (echinocandins, gliotoxin, lanomycin-type polyenes, etc.). Among the four choices: (A) Lipid metabolism relies on fatty acid synthases, desaturases, and elongases—not NRPS; (C) Spheroidene is a carotenoid synthesized by phytoene synthase, carotenoid desaturases, and lycopene cyclases—not NRPS; (D) One-carbon metabolism involves folate-cycle enzymes (SHMT, methionine synthase, formyltransferases)—not NRPS. Only (B) Antifungal biosynthesis is mechanistically consistent with a large NRPS producing a fungal secondary metabolite. A model recognizing NRPS architecture can eliminate A, C, and D on mechanistic grounds and select B.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognition of NRPS domain signatures (SGSTG, HHxxxDG, GGES/GGDS) from the sequence, combined with general knowledge that fungal NRPS enzymes produce secondary metabolites such as antifungals rather than primary metabolites (lipids, carotenoids, one-carbon units), provides a concrete and credible inference that distinguishes B from A, C, and D without requiring the specific UniProt annotation for this protein."
  },
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "H3",
      "H1"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV4 explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305|PubMed:33857369). The protein is a nonribosomal peptide synthetase (EC 6.3.2.-) in the lanomycin biosynthesis cluster of the fungus Pyrenophora dematioidea. Lanomycin is a known polyene antifungal compound. The reference (Liu et al. 2021, JACS) describes targeted genome mining of CYP51-inhibitor biosynthetic gene clusters, confirming the antifungal biosynthesis context. The sequence matches the benchmark exactly."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000305 (inferred by curator from PubMed:33857369), not direct experimental pathway reconstitution, though the supporting paper provides genomic and functional evidence.",
    "The entry was first publicly released in February 2025; the author's source snapshot is unknown but the sequence matches exactly.",
    "NRPS domain recognition from sequence alone is a computational inference; however, the domain signatures here are canonical and unambiguous."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct pathway classes. NRPS enzymes are incompatible with lipid metabolism (A), carotenoid/spheroidene biosynthesis (C), and one-carbon metabolism (D) based on well-established biochemistry. Only antifungal biosynthesis (B) is consistent with NRPS function in fungi. No alternative choice is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0022",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV4 explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305|PubMed:33857369). The protein is a nonribosomal peptide synthetase (EC 6.3.2.-) in the lanomycin biosynthesis cluster of the fungus Pyrenophora dematioidea. Lanomycin is a known polyene antifungal compound. The reference (Liu et al. 2021, JACS) describes targeted genome mining of CYP51-inhibitor biosynthetic gene clusters, confirming the antifungal biosynthesis context. The sequence matches the benchmark exactly.",
    "evidence_ids": ["C5", "C4", "C6", "H3", "H1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence displays hallmark nonribosomal peptide synthetase (NRPS) domain signatures: the 'SGSTG' adenylation-domain motif, 'GGES' and 'GGDS' A-domain sub-motifs, and the 'HHxxxDG' condensation-domain signature (e.g., 'HHAMFDGITLGQ'). NRPS enzymes are large multi-modular assembly-line catalysts that produce secondary metabolites (peptides, lipopeptides, polyene-polyketide hybrids). From transferable knowledge of fungal secondary metabolism, NRPS clusters in fungi commonly synthesize antifungal agents (echinocandins, gliotoxin, lanomycin-type polyenes, etc.). Among the four choices: (A) Lipid metabolism relies on fatty acid synthases, desaturases, and elongases—not NRPS; (C) Spheroidene is a carotenoid synthesized by phytoene synthase, carotenoid desaturases, and lycopene cyclases—not NRPS; (D) One-carbon metabolism involves folate-cycle enzymes (SHMT, methionine synthase, formyltransferases)—not NRPS. Only (B) Antifungal biosynthesis is mechanistically consistent with a large NRPS producing a fungal secondary metabolite. A model recognizing NRPS architecture can eliminate A, C, and D on mechanistic grounds and select B.",
    "missing_item_specific_fact": "",
    "reason": "Recognition of NRPS domain signatures (SGSTG, HHxxxDG, GGES/GGDS) from the sequence, combined with general knowledge that fungal NRPS enzymes produce secondary metabolites such as antifungals rather than primary metabolites (lipids, carotenoids, one-carbon units), provides a concrete and credible inference that distinguishes B from A, C, and D without requiring the specific UniProt annotation for this protein."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct pathway classes. NRPS enzymes are incompatible with lipid metabolism (A), carotenoid/spheroidene biosynthesis (C), and one-carbon metabolism (D) based on well-established biochemistry. Only antifungal biosynthesis (B) is consistent with NRPS function in fungi. No alternative choice is defensible."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000305 (inferred by curator from PubMed:33857369), not direct experimental pathway reconstitution, though the supporting paper provides genomic and functional evidence.",
    "The entry was first publicly released in February 2025; the author's source snapshot is unknown but the sequence matches exactly.",
    "NRPS domain recognition from sequence alone is a computational inference; however, the domain signatures here are canonical and unambiguous."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV4",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "b09f5bc596e360b38514b0be6e8b7293c64d426438082f8f28a697222a7f4980",
  "benchmark_sequence_length": 1325,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "current_source_sequence_sha256": "b09f5bc596e360b38514b0be6e8b7293c64d426438082f8f28a697222a7f4980",
  "current_source_sequence_length": 1325,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 4,
  "selected_historical_version": {
    "accession": "P0DXV4",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "LAN2_PYRDE",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd",
  "selected_historical_source_sequence_sha256": "b09f5bc596e360b38514b0be6e8b7293c64d426438082f8f28a697222a7f4980",
  "selected_historical_source_sequence_length": 1325,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV4\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Helminthosporium dematioideum\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Pleosporomycetidae\",\"Pleosporales\",\"Pleosporineae\",\"Pleosporaceae\",\"Pyrenophora\"],\"scientificName\":\"Pyrenophora dematioidea\",\"taxonId\":139229}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Lanomycin biosynthesis cluster protein 1\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"6.3.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Nonribosomal peptide synthetase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV4.json",
  "source_sha256": "6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd",
  "retrieved_utc": "2026-11-02T04:29:46.025798+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"TTI-1096\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4",
  "source_sha256": "ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd",
  "retrieved_utc": "2026-11-02T04:29:48.541613+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   LAN2_PYRDE              Reviewed;        1325 AA.\nAC   P0DXV4;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=Nonribosomal peptide synthetase {ECO:0000303|PubMed:33857369};\nDE            EC=6.3.2.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Lanomycin biosynthesis cluster protein 1 {ECO:0000303|PubMed:33857369};\nGN   Name=ORF2 {ECO:0000303|PubMed:33857369};\nOS   Pyrenophora dematioidea (Helminthosporium dematioideum).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae;\nOC   Pyrenophora.\nOX   NCBI_TaxID=139229;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4",
  "source_sha256": "ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd",
  "retrieved_utc": "2026-11-02T04:29:48.541613+00:00",
  "source_locator": "lines 15-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=TTI-1096;\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4",
  "source_sha256": "ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd",
  "retrieved_utc": "2026-11-02T04:29:48.541613+00:00",
  "source_locator": "lines 37-37",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 22. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
